SEMBYDE Trademark

Trademark Overview

On Tuesday, February 15, 2011, a trademark application was filed for SEMBYDE with the United States Patent and Trademark Office. The USPTO has given the SEMBYDE trademark a serial number of 85242347. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 22, 2014. This trademark is owned by Glaxo Group Limited. The SEMBYDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
sembyde

General Information

Serial Number85242347
Word MarkSEMBYDE
Filing DateTuesday, February 15, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 22, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 21, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 18, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, September 22, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 22, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 25, 2014EXTENSION 5 GRANTED
Tuesday, February 11, 2014EXTENSION 5 FILED
Tuesday, February 11, 2014TEAS EXTENSION RECEIVED
Thursday, September 12, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2013EXTENSION 4 GRANTED
Tuesday, August 13, 2013EXTENSION 4 FILED
Friday, September 6, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 13, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 25, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 25, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 7, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 6, 2013EXTENSION 3 GRANTED
Monday, February 4, 2013EXTENSION 3 FILED
Monday, February 4, 2013TEAS EXTENSION RECEIVED
Saturday, August 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 24, 2012EXTENSION 2 GRANTED
Tuesday, August 14, 2012EXTENSION 2 FILED
Wednesday, August 22, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 14, 2012TEAS EXTENSION RECEIVED
Friday, January 27, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 25, 2012EXTENSION 1 GRANTED
Wednesday, January 25, 2012EXTENSION 1 FILED
Wednesday, January 25, 2012TEAS EXTENSION RECEIVED
Tuesday, August 16, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2011PUBLISHED FOR OPPOSITION
Thursday, May 12, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 12, 2011ASSIGNED TO EXAMINER
Friday, February 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 18, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

sembyde pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological